Dutch food-tech company Revyve has secured nearly EUR24m in Series B financing, lifting its total funding above EUR40m.
The new capital will help accelerate the company’s rollout of yeast-based proteins designed to replace eggs and additives across mainstream food categories.
The funding round was co-led by ABN AMRO Sustainable Impact Fund and Invest-NL, with additional backing from regional investor Brabantse Ontwikkelings Maatschappij, as well as strategic investors Danstar Ferment, an affiliate of Lallemand Bio-Ingredients, and Grey Silo Ventures, the venture capital arm of Cereal Docks Group. Existing investors Oost NL and Royal Cosun also increased their commitments. The investor mix blends institutional, public, and strategic expertise aimed at supporting Revyve’s ambition to reshape the alternative protein market with clean-label solutions.
Revyve produces functional yeast proteins that replicate the performance of eggs in baked goods, sauces, alternative meats, and plant-based dairy. Unlike many substitutes, the company’s ingredients are natural, more sustainable, and cost-competitive—appealing to food manufacturers navigating rising egg prices, growing scrutiny of ultra-processed foods, and pressure to reduce carbon footprints.
“Food manufacturers are cutting back on eggs to offset increasing prices and reach sustainability targets, but replicating their unique functionality is crucial to maintaining the texture and mouthfeel consumers are used to. This is exactly where our Yeast Proteins come in, providing an affordable and clean label solution for egg replacement or egg reduction,” said Cedric Verstraeten, Revyve’s chief executive. “This funding round marks a tipping point for us: allowing us to modularly scale production and branch out to more food categories and serve our sustainable solutions to larger customers worldwide.”
Revyve recently launched its first large-scale production facility in Dinteloord, the Netherlands. Already running at capacity, the site has demonstrated the company’s ability to deliver industrial volumes. With the new financing, Revyve plans to expand output to more than 1,600 tons annually, ensuring a stable supply for global customers.
“Strong regional support from both the Wageningen and Brabant ecosystems has enabled us to scale to industrial levels in record time,” Verstraeten said. “With a stellar team and strong investor backing, we have an incredibly solid foundation for global expansion.”
Investors underscored their confidence in the company’s proprietary technology and market potential.
“We are excited to partner with Revyve as they pioneer pressing sustainable alternatives to traditional egg ingredients,” said Hanna Zwietering, senior investment manager at ABN AMRO Sustainable Impact Fund. “Their solution addresses a critical need in the food transition: scalable ingredients with a low environmental footprint and compelling economics for food manufacturers. We believe this combination of commercial viability and measurable sustainable benefits makes Revyve uniquely positioned to grow into a global leader.”
Lisette Kersting-van der Boog, senior investment manager at Invest-NL, said: “With their functional egg-replacement ingredients, Revyve can play a major role in accelerating the global protein transition and fostering circular solutions that reduce pressure on land, water and animals. We are proud to invest in this Dutch company, which strengthens the country’s innovative power with a pioneering technology that has the potential to transform food production worldwide.”
Ingrid Nieweg, investment manager at Brabantse Ontwikkelings Maatschappij, added: “Revyve’s plans align seamlessly with our mission to position Brabant as the Scale-Up Plant of Europe. Their breakthrough technology not only contributes to a more sustainable food system but also exemplifies the kind of bold innovation we aim to foster in the region. We’re proud to support Revyve in scaling their impact from Brabant to the world.”
Lallemand Bio-Ingredients and Grey Silo Ventures also participated in the Series B round, contributing additional expertise in yeast innovation and agri-food development.
Find out more at: https://revyve.bio/